INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic

See also
Status	Clinical Trial	Phase
Completed	`NCT02128100` - Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer	Phase 2
Not yet recruiting	`NCT05047991` - Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma	Phase 2
Completed	`NCT03590275` - Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX
Recruiting	`NCT05265663` - Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients	N/A
Recruiting	`NCT05642962` - Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)	Phase 1/Phase 2
Recruiting	`NCT06160323` - Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer	N/A
Active, not recruiting	`NCT04156087` - Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer	Phase 2
Not yet recruiting	`NCT06387368` - Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer	Phase 4
Active, not recruiting	`NCT03941093` - Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer	Phase 3
Recruiting	`NCT03165591` - Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer	Phase 1/Phase 2
Recruiting	`NCT05549414` - Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System	N/A
Recruiting	`NCT06388967` - Pancreatic Cancer Detection Consortium
Not yet recruiting	`NCT06375967` - EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)	N/A
Withdrawn	`NCT04852367` - PanDox: Targeted Doxorubicin in Pancreatic Tumours	Phase 1
Recruiting	`NCT03977233` - Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer	Phase 2
Recruiting	`NCT03964064` - I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer	N/A
Not yet recruiting	`NCT06361030` - Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer	Phase 2
Recruiting	`NCT05424159` - Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer	N/A
Terminated	`NCT01887041` - Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer	Phase 4
Active, not recruiting	`NCT03984214` - Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer	Phase 3

NCT number	NCT04116073
Study type	Interventional
Source	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contact	Colleen Apostal, RN
Phone	410-614-3644
Email	GIClinicalTrials@jhmi.edu
Status	Recruiting
Phase	Phase 2
Start date	April 9, 2020
Completion date	August 2028

INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms